AZN’s Debt-to-Equity Ratio at 0.73: What It Means for Astrazeneca plc ADR’s Future

The market performance of Astrazeneca plc ADR’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $76.56 on 04/25/23, while the lowest value for the same duration was $61.70 on 02/08/24.

52-week price history of AZN Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Astrazeneca plc ADR’s current trading price is -18.68% away from its 52-week high, while its distance from the 52-week low is 0.91%. The stock’s price range during the 52-week period has remained between $61.70 and $76.56. In the Healthcare sector, the company’s shares saw a trading volume of around 5.88 for the day, which was evidently higher than the average daily volume of 2.33 over the past three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Market Capitalization and Financial Performance: An In-Depth Look

Astrazeneca plc ADR (AZN) has experienced a quarterly decline of -2.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 193.03B and boasts a workforce of Aug 10 2023 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 65.84, with a change in price of -4.37. Similarly, Astrazeneca plc ADR recorded 5,904,923 in trading volume during the last 100 days, posting a change of -6.56%.

Examining AZN’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.59.

AZN Stock Stochastic Average

As of today, Astrazeneca plc ADR’s raw stochastic average for the last 50 days stands at 6.81%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 7.08%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 20.18% and 25.59%, respectively.

AZN Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -7.56%. However, over the last six months, the performance has been stronger by -11.49%. The price of AZN decreased -10.51% over the last 30 days. And in the last five days, it has fallen by -5.15%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts